tiprankstipranks
Ugro Capital Limited (IN:UGROCAP)
:UGROCAP
India Market
Want to see IN:UGROCAP full AI Analyst Report?

Ugro Capital Limited (UGROCAP) AI Stock Analysis

6 Followers

Top Page

IN:UGROCAP

Ugro Capital Limited

(UGROCAP)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - Gpt-5.6Sol)
Rating:53Neutral
Price Target:
₹88.00
▼(-5.34% Downside)
Action:Reiterated
Date:08/06/26
The score is held back mainly by higher balance-sheet risk (debt-to-equity ~3.55x) and historically unstable cash flows despite a 2026 improvement, alongside weak long-term price trend/momentum (well below the 200-DMA, negative MACD). These risks are partially offset by strong revenue growth and an inexpensive valuation (P/E 6.82).
Positive Factors
MSME lending focus
A focused MSME lending model targets a large, specialized credit market where sector knowledge can support underwriting and product design. Concentration on selected sectors and direct origination may help build repeatable processes and deepen borrower relationships over time.
Negative Factors
High leverage
Elevated leverage reduces financial flexibility for a credit-services business and increases sensitivity to funding costs, refinancing conditions, and credit stress. Because leverage has stayed high for several years, it represents a persistent constraint on resilience and future capital allocation.
Read all positive and negative factors
Positive Factors
Negative Factors
MSME lending focus
A focused MSME lending model targets a large, specialized credit market where sector knowledge can support underwriting and product design. Concentration on selected sectors and direct origination may help build repeatable processes and deepen borrower relationships over time.
Read all positive factors

Ugro Capital Limited (UGROCAP) vs. iShares MSCI India ETF (INDA)

Ugro Capital Limited Business Overview & Revenue Model

Company Description
UGRO Capital Limited functions as a non-banking financial company primarily engaged in offering various lending services. The firm provides business financing specifically targeting diverse sectors such as healthcare, education, chemicals, food pr...
How the Company Makes Money
UGROCAP primarily makes money by extending loans to MSMEs and earning interest income (and related lending yield) on the outstanding loan book. Its core revenue stream is the net interest income generated from the spread between (a) interest earne...

Ugro Capital Limited Financial Statement Overview

Summary
Top-line growth is a positive (2026 revenue up 14.56%) and net margins are healthy (11.86%), but the financial profile is constrained by high leverage (debt-to-equity ~3.55x) and historically volatile cash generation (multi-year negative operating/free cash flow before turning positive in 2026). Mixed operating profitability signals also raise earnings-quality risk.
Income Statement
62
Positive
Balance Sheet
44
Neutral
Cash Flow
40
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue19.47B14.74B9.64B7.07B4.88B2.68B
Gross Profit7.35B2.23B1.29B995.24M678.77M624.11M
EBITDA3.16B-140.04M2.62B2.19B1.07B348.23M
Net Income2.09B1.75B1.44B1.19B397.76M145.51M
Balance Sheet
Total Assets0.00140.75B91.68B62.80B43.06B28.54B
Cash, Cash Equivalents and Short-Term Investments0.0018.25B5.53B883.64M2.12B1.60B
Total Debt0.00108.68B69.04B46.53B31.49B18.31B
Total Liabilities-29.06B111.69B71.22B48.42B33.22B18.88B
Stockholders Equity29.06B29.06B20.46B14.38B9.84B9.67B
Cash Flow
Free Cash Flow-669.50M1.71B-25.00B-15.38B-12.61B-11.46B
Operating Cash Flow-556.27M2.14B-24.74B-15.35B-12.20B-11.32B
Investing Cash Flow-3.88B-19.64B-799.24M-2.30B-845.42M413.80M
Financing Cash Flow15.07B27.51B26.55B18.14B12.79B10.23B

Ugro Capital Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price92.96
Price Trends
50DMA
93.18
Negative
100DMA
97.13
Negative
200DMA
118.72
Negative
Market Momentum
MACD
-2.45
Positive
RSI
33.27
Neutral
STOCH
29.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:UGROCAP, the sentiment is Negative. The current price of 92.96 is above the 20-day moving average (MA) of 88.65, below the 50-day MA of 93.18, and below the 200-day MA of 118.72, indicating a bearish trend. The MACD of -2.45 indicates Positive momentum. The RSI at 33.27 is Neutral, neither overbought nor oversold. The STOCH value of 29.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:UGROCAP.

Ugro Capital Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
₹67.30B26.720.13%22.60%21.00%
62
Neutral
₹110.64B22.8327.55%28.90%
59
Neutral
₹53.70B13.580.68%23.25%21.56%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
55
Neutral
₹35.01B34.975.19%
53
Neutral
₹13.28B5.803.06%35.80%-5.33%
47
Neutral
₹41.83B-10.611.08%-1.90%-151.41%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:UGROCAP
Ugro Capital Limited
85.33
-93.62
-52.32%
IN:INDOSTAR
IndoStar Capital Finance Limited
253.45
-18.80
-6.91%
IN:MASFIN
MAS Financial Services Ltd.
295.40
-13.44
-4.35%
IN:MUTHOOTMF
Muthoot Microfin Ltd
198.15
31.00
18.55%
IN:PAISALO
Paisalo Digital Ltd.
79.18
41.69
111.20%
IN:SBFC
SBFC Finance Limited
98.52
-8.18
-7.67%

Ugro Capital Limited Corporate Events

UGRO Capital Sets September Meetings on Profectus Amalgamation
Aug 14, 2026
UGRO Capital has dispatched notices to convene separate meetings of its equity shareholders, secured creditors and unsecured creditors to consider and approve a proposed Scheme of Amalgamation with Profectus Capital Private Limited. The meetings, ...
Ugro Capital Shuts Trading Window Ahead of June-Quarter Results
Jun 28, 2026
Ugro Capital Limited has announced that its trading window will be closed from June 29, 2026 until 48 hours after the declaration of its unaudited financial results for the quarter ending June 30, 2026, in line with SEBI’s Prohibition of Ins...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 06, 2026